AIDS Research and Therapy

Papers
(The TQCC of AIDS Research and Therapy is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis63
COVID-19 and HIV infection co-pandemics and their impact: a review of the literature55
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy46
The effect of “universal test and treat” program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, So29
Determinants of comprehensive knowledge of HIV/AIDS among reproductive age (15–49 years) women in Ethiopia: further analysis of 2016 Ethiopian demographic and health survey27
Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 202025
Adolescents living with HIV, complex needs and resilience in Blantyre, Malawi25
The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review25
Trends and correlates of HIV prevalence among adolescents in South Africa: evidence from the 2008, 2012 and 2017 South African National HIV Prevalence, Incidence and Behaviour surveys24
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia22
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)20
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals19
JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review19
Determinants of viral suppression among adolescents on antiretroviral treatment in Ehlanzeni district, South Africa: a cross-sectional analysis18
Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study18
Addressing advanced HIV disease and mortality in global HIV programming18
HIV/AIDS late presentation and its associated factors in China from 2010 to 2020: a systematic review and meta-analysis17
Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview17
Food insecurity and the risk of depression in people living with HIV/AIDS: a systematic review and meta-analysis16
Social response to the delivery of HIV self-testing in households: experiences from four Zambian HPTN 071 (PopART) urban communities16
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial15
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4+ T cell count15
“They have this not care – don’t care attitude:” A Mixed Methods Study Evaluating Community Readiness for Oral PrEP in Adolescent Girls and Young Women in a Rural Area of South Africa14
The prevalence of depression among adolescent with HIV/AIDS: a systematic review and meta-analysis13
Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings13
Daily variations of gut microbial translocation markers in ART-treated HIV-infected people13
Treatment outcomes among adults with HIV/non-communicable disease multimorbidity attending integrated care clubs in Cape Town, South Africa13
The role of CD38 in HIV infection13
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda12
Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs12
Tenofovir alafenamide nephrotoxicity: a case report and literature review12
Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis12
CRISPR/Cas9: a tool to eradicate HIV-112
A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting12
Level of knowledge, acceptability, and willingness to use oral fluid HIV self-testing among medical students in Kilimanjaro region, Tanzania: a descriptive cross-sectional study12
Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy12
Evidence and implication of interventions across various socioecological levels to address pre-exposure prophylaxis uptake and adherence among men who have sex with men in the United States: a systema11
Predictors of mortality rate among adult HIV-positive patients on antiretroviral therapy in Metema Hospital, Northwest Ethiopia: a retrospective follow-up study11
Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda11
Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–201711
Communication needs for improved uptake of PrEP and HIVST services among key populations in Nigeria: a mixed-method study10
Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi10
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador10
Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana10
Association between depression and HIV treatment outcomes in a US military population with HIV infection9
Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced, patients living with HIV9
Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series9
Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U9
Epidemiology of survival pattern and its predictors among HIV positive patients on highly active antiretroviral therapy in Southern Ethiopia public health facilities: a retrospective cohort study9
Influence of intensified adherence counselling on viral load suppression of people receiving antiretroviral therapy at a health centre IV in southwestern Uganda: a qualitative study9
Routine HIV clinic visit adherence in the African Cohort Study9
Factors associated with antiretroviral therapy adherence among people living with HIV in Haiti: a cross-sectional study9
Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir9
Willingness to use HIV pre-exposure prophylaxis and associated factors among men who have sex with men in Liuzhou, China9
Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study8
Increased HIV in Greater Kinshasa Urban Health Zones: Democratic Republic of Congo (2017–2018)8
The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau8
Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis8
Effect of mobile text messages on antiretroviral medication adherence and patient retention in early HIV care: an open-label, randomized, single center study in south Florida8
Utility of HIV support groups in advancing implementation research in resource-limited settings: experiences from an urban-setting HIV support group in Zimbabwe7
Prevalence and associated factors of HIV self-testing among men who have sex with men in Ningbo, China: a cross-sectional study7
Prevalence and factors associated with adverse drug events among patients on dolutegravir-based regimen at the Immune Suppression Syndrome Clinic of Mbarara Regional Referral Hospital, Uganda: a mixed7
Disclosure and health-related outcomes among children living with HIV and their caregivers7
Advanced HIV disease management practices within inpatient medicine units at a referral hospital in Zambia: a retrospective chart review7
Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors7
Knowledge and determinants of women’s knowledge on vertical transmission of HIV and AIDS in South Africa7
Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies7
AIDS-associated Talaromyces marneffei central nervous system infection in patients of southwestern China7
Rapid Antiretroviral Therapy (ART) Initiation at a Community-Based Clinic in Jackson, MS7
Fecal carriage of extended spectrum beta-lactamase producing Enterobacteriaceae among HIV infected children at the University of Gondar Comprehensive Specialized Hospital Gondar, Ethiopia6
Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials6
What is polypharmacy in people living with HIV/AIDS? A systematic review6
Survival of people aged 50 years and older by HIV and HIV treatment status: findings from three waves of the SAGE-Wellbeing of Older People Study (SAGE-WOPS) in Uganda6
The expansion of a patient tracer programme to identify and return patients loss to follow up at a large HIV clinic in Trinidad6
Views among Malawian women about joining HIV prevention clinical trials when pregnant6
Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review6
MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review6
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon6
A systematic review and meta-analysis of HIV associated neurocognitive disorders (HAND) among people with HIV in Ethiopia6
Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa: a systematic review and meta-analysis6
Habit formation in support of antiretroviral medication adherence in clinic-enrolled HIV-infected adults: a qualitative assessment using free-listing and unstructured interviewing in Kampala, Uganda6
Psychiatric disorders in adolescents living with HIV in Botswana5
HIV prevalence and associated risk factors among young tertiary student men who have sex with men (MSM) in Nairobi, Kenya: a respondent-driven sampling survey5
The lived experience of HIV-infected patients in the face of a positive diagnosis of the disease: a phenomenological study5
Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala5
Associations between antiretroviral therapy-related experiences and mental health status among people living with HIV in China: a prospective observational cohort study5
A pilot pragmatic trial of a “what matters most”-based intervention targeting intersectional stigma related to being pregnant and living with HIV in Botswana5
Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study5
Linkage to intensive adherence counselling among HIV-positive persons on ART with detectable viral load in Gomba district, rural Uganda5
Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study5
HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania5
The perceptions of older people living with hiv/aids towards physical activity and exercise5
Influence of depression and interpersonal support on adherence to antiretroviral therapy among people living with HIV5
Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-5
Closing gaps in histoplasmosis: clinical characteristics and factors associated with probable/histoplasmosis in HIV/AIDS hospitalized patients, a retrospective cross-sectional study in two tertiary ce5
HIV and syphilis testing behaviors among heterosexual male and female sex workers in Uganda5
The transient effect of a peer support intervention to improve adherence among adolescents and young adults failing antiretroviral therapy in Harare, Zimbabwe: a randomized control trial5
The impact of gender and the social determinants of health on the clinical course of people living with HIV in Myanmar: an observational study5
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults5
Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States5
Pre-exposure prophylaxis makes it possible to better live one’s sexuality and guide men who have sex with men towards a responsible approach to their health: a phenomenological qualitative study about5
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda5
Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection5
Disability and self-care living strategies among adults living with HIV during the COVID-19 pandemic5
Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States5
0.030441045761108